Number of STIs continues to rise at Dutch STI clinics In the first half of this year more STIs were found in people who have been tested at Dutch STI clinics. The increase pertains to all STIs, with the exception of HIV.
European Antibiotic Awareness Day 2016 Friday 18 November is European Antibiotic Awareness Day. On this day, throughout Europe attention focuses on the threat of antibiotic resistance to people and animals.
EU legislation genetically modified microbial biocontrol agents is fit for purpose EU legislative instruments are sufficient to ensure the safety of such products.
Surveillance and developments National Immunisation Programme 2015-2016 The report provides an overview of effectiveness and safety of vaccines and vaccine research.
RIVM starts field research into rubber granulate RIVM has started to take samples of rubber granulate from 100 synthetic turf fields in the Netherlands.
Need for strategy to assess endocrine disrupting chemicals There is a need for a strategy to enable companies and governments to assess whether chemicals are endocrine disrupting.
Application of personalised medicine: opportunities and challenges Pharmacotherapy based on individual patient characteristics such as genetic makeup, offers many potential benefits towards more effective treatment of a patients’ disease.
Strict diet combats aging diseases Mice with a severe aging disease live three times longer if they eat thirty percent less. Moreover, they age much healthier than mice that eat as much as they want.
Improved protection against pertussis The international PERISCOPE project has been granted a 30 million Euro European subsidy in order to better map the immune response to pertussis infection and vaccination.
RIVM to research safe design for new nanoparticles RIVM will be working alongside a consortium of 23 international partners on a safe design for ‘new’ nanoparticles.